Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin C for distributive shock in intensive care
ACTRN12617001392358Phase 2Recruiting
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium ascorbate in Vasoplegia, Systemic Inflammatory Response Syndrome (SIRS) and septic shock (2 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoints: Duration of vasopressor usage and Total dose of vasopressor usage. Started Jul 2018; status: recruiting.
02
Drugs
sodium ascorbate
03
Conditions
VasoplegiaSystemic Inflammatory Response Syndrome (SIRS)septic shock
Beyond the preview
Go deeper on ACTRN12617001392358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001392358.